Table 3

Lung adenocarcinoma: predictive significance of each parameter

Tumor cell stainingCovariatesP
Death from other causesSurvivorsRelapsesSurvival (mo)No. of patients
Differentiationa
+4253136 ± 25600.009
762220.56 ± 22.6935
Bcl-2b
+47741.60 ± 28.91180.009
10145327.60 ± 23.3577
ABH antigensb
+661733.19 ± 22.44290.024
8154229.30 ± 26.0965
p53b
+553427.53 ± 24.30440.076
9162532.50 ± 25.7550
Pan-Rasb
+572022.81 ± 18.11320.43
9143923.85 ± 19.2762
Ki-RAS mutations
+21424.13 ± 18.85120.34
12205618.56 ± 18.1983
C-erbB2b
+24635.05 ± 32.67120.34
12175429.56 ± 23.8083
Blood types
O672423.09 ± 25.52370.018
B14842.38 ± 28.03130.32
A562731.58 ± 20.02380.39
AB23133.17 ± 32.5260.26
Sex
Male12175428.17 ± 24.36830.0014
Female24644.69 ± 25.2112
  • a Tumor histological subtyping: +, well-differentiated; −, moderately or poorly differentiated.

  • b Immunohistochemistry: +, positive tumor staining; −, negative tumor staining.

  • c Univariate Wilcoxon rank test pooled over tumor stage.